2017 Dodge Journey Crossroad Plus
2.4 L • I4 • 173 hp • FWD • AT
3C4PDCGB4HT560159
Sales history: 1
Highlights
Condition
Run and drive
Seller
Unknown
Key included
Yes
Docs
Good
History
1 record
Drive
2.4 L • I4 • 173 hp • FWD • AT
Odometer
72,324 mi ≈ 116,394 km
Primary damage
Rear end
Secondary damage
Minor dent scratches
Docs
TX • Salvage
Extra
Auction
VIN
3C4PDCGB4HT560159
Lot number
63101325
Copart
Sale status
Sold
Location
Abilene, TX
Description
Fuel type
Gasoline
Body color
Black
Body type
SUV
Trim
Crossroad Plus
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Dodge models
2017 Dodge Journey Crossroad Plus • 2.4 L • I4 • 173 hp • FWD • Automatic • Copart Lot: 63101325 • VIN: 3C4PDCGB4HT560159
Find out more about this 2017 Dodge Journey Crossroad Plus, available at the Copart salvage car auction as lot #63101325 in Abilene, TX. This car has Rear end main damage. It is listed with Run and drive start condition code. Odometer shows 72,324 mi. This Black Dodge Journey SUV is equipped with Gasoline 2.4 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 3C4PDCGB4HT560159 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
